There is little doubt that Elon Musk’s flamethrowers are the hottest new commodity right now. After all, the fiery device produced by The Boring Company have just been sold out. However, it looks like consumers have already started misusing the dangerous product despite its lengthy terms and conditions.
The Boring Company finally rolled out Not A Flamethrower at a celebrated pick up event held at the company’s headquarters. People who had pre-ordered the gadgets were given a chance to sample the power of the flamethrower on unfortunate marshmallows. Although safety was reinforced during the event, things took a dangerous turn once everyone got home.
The Boring Company’s Not A Flamethrower were sold out in February but have only started shipping this summer.
Most of the customers who shelled out $500 for the flamethrowers were actually celebrities and social media influencers. For instance, YouTuber Justine Ezarik admitted that she damaged some artificial grass while using the fireblaster for a cooking video. One man lit a huge cigar with his device while another almost lost his toes while playing with the device. Not surprisingly, some people are already concerned about Elon Musk’s decision to mass produce the flamethrowers.
Operating the flamethrower takes plenty of practice.
Twitter user Marshall Brentnall asked why The Boring Company had to roll out 20,000 flamethrowers to the masses.
“What possible reason is there for this product to be made available to consumers? For a product such as this to be available for purchase is wrong and very well unsafe. Someone will get hurt,” he wrote.
Another Twitter user Ketan Joshi questioned Elon Musk’s motivations for making the dangerous flamethrowers in the first place.
“One good way to test whether a public figure is sincere about climate action is whether they sell flamethrowers to private citizens during California’s fire season,” he wrote.
Elon Musk insists that safety is important, especially when using your flamethrower around babies.
The Boring Company sold all 20,000 units of Not A Flamethrower. As of writing, there have been no reports about flamethrower-related accidents.
NASA’s Curiosity Rover Finds Ancient Organics On Mars, Possible Life On Planet In The Past
The new discovery might confirm life thrived on the Red Planet billions of years ago.
Curiosity has made an exciting discovery on the surface of Mars. The rover has just found possible evidence of life on the planet billions of years ago. NASA might not quite ready to confirm that creatures once roamed the Red Planet. Nevertheless, the agency believes that the findings could mean positive things for future missions.
The NASA rover has found organic molecules in sedimentary rocks near the planet's surface. These molecules may contain hydroxen, carbon, oxygen, and nitrogen and are usually associated with life. However, their presence in the billion-year-old rocks does not confirm life on Mars just yet.
NASA's Jen Eigenbrode believes Mars may have been habitable billions of years ago.
NASA’s ‘Clean Rooms’ Are Not So Clean, No Thanks to Bacteria That Eat Cleaning Products
And they can contaminate other worlds when they hitch a ride to outer space.
At NASA, they have what they call 'clean rooms,' where they assemble their spacecrafts. These pristine chambers are religiously cleaned and scrubbed with alcohol-based solvents. Every matter must go through several filters to ensure the area is never contaminated; every person must be in the proper coveralls when entering the rooms - all these to prevent Earth microbes from reaching and contaminating other worlds during NASA explorations, as part of the international planetary protection treaty.
But even with NASA's meticulous standards, it is impossible to completely sterilize the clean rooms. Bacteria can still thrive in their immaculate walls.
The tough Acinetobacter bacteria can be found in NASA's clean rooms.
Groundbreaking Study Can Help Many Women with Breast Cancer Skip Chemotherapy
This new finding is expected to make a radical change in cancer treatments.
According to a new major international study, women with early-stage breast cancer who would receive chemotherapy under current standards do not actually need it. The study, titled Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer and published by The New England Journal of Medicine, is expected to make a significant impact in cancer treatments.
The study found that gene tests on tumor samples can identify breast cancer patients who do not need to undergo chemotherapy. Instead, they can take a drug called tamoxifen that blocks the hormone estrogen or stops the body from making it, and undergo endocrine therapy. The findings apply to an estimated 60,000 women a year in the United States alone.